Key result
PCI shows no difference in MACCE compared to CABG for intermediate SYNTAX II scores.
Why the study?
Whether to treat patients with intermediate SYNTAX II score by PCI using second-generation drug-eluting stents or by CABG remains an area of clinical uncertainty for interventional cardiologists.
Does percutaneous coronary intervention (PCI) using second generation drug eluting stents reduce major adverse cardiac or cerebrovascular events compared to coronary artery bypass grafting (CABG) in patients with intermediate SYNTAX II score?
Cohort (n=214)
Does percutaneous coronary intervention (PCI) using second generation drug eluting stents reduce major adverse cardiac or cerebrovascular events compared to coronary artery bypass grafting (CABG) in patients with intermediate SYNTAX II score?
Hazard Ratio: 1.65 (95% CI 0.87–3.14)
Absolute Event Rate: 20.2% vs 14.3%
p-value: p=0.13
In patients with an intermediate SYNTAX II score, PCI with second-generation drug-eluting stents showed no statistically significant difference in MACCE at 40 months compared to CABG, although CABG provided better quality of life.
No MACCE difference with PCI versus CABG; leaves open optimal strategy and requires randomized trials in intermediate SYNTAX II patients.
Patients with intermediate SYNTAX II score have been representing a confusion in our daily practice for interventional cardiologists whether to treat them by percutaneous coronary intervention (PCI) using second generation drug eluting stents or by coronary artery bypass grafting (CABG). We enrolled 214 consecutive patients with intermediate SYNTAX II score to undergo revascularization (109 patients underwent PCI and 105 patients underwent CABG) after Heart Team discussion. We compared both procedures with respect to the primary composite end point of major adverse cardiac or cerebrovascular events (all-cause mortality, myocardial infarction, target vessel revascularization or stroke) at 40 months post procedure. At 40 months post revascularization procedure, the primary end-point occurred in 22 patients and 15 patients in the PCI and CABG groups, respectively (hazard ratio, 1.65; 95% confidence interval, 0.87-3.14; P = 0.13). No significant differences were detected between both groups regarding the composite incidence of all-cause mortality, myocardial infarction, target vessel revascularization, and stroke. CABG significantly provided better quality of life than PCI for patients with intermediate SYNTAX II score. In patients with intermediate SYNTAX II score, there was no statistically significant difference between the PCI using second generation drug eluting stents and CABG with respect to the incidence of MACCE at 40 months post revascularization procedure.
No takes yet. Share an insight, caveat, or question.
Etman et al. (2022) conducted a cohort in Intermediate SYNTAX II score (n=214). Percutaneous coronary intervention (PCI) using second generation drug eluting stents vs. Coronary artery bypass grafting (CABG) was evaluated on Major adverse cardiac or cerebrovascular events (all-cause mortality, myocardial infarction, target vessel revascularization or stroke) (HR 1.65, 95% CI 0.87-3.14, p=0.13). PCI using second-generation drug-eluting stents showed no significant difference in MACCE compared to CABG in patients with intermediate SYNTAX II score (HR 1.65; 95% CI 0.87-3.14; P=0.13).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: